How long does Vivitrol last?
- By Robert Mauer
- Reviewed by: Dr. Janaka Hanvey, PhD
Vivitrol is designed to last approximately one month because it uses an extended-release formulation that gradually releases naltrexone into the body over several weeks. The medication is administered as a long-acting intramuscular injection intended to maintain opioid receptor blockade during the active dosing period. This extended-release structure allows the medication to provide sustained pharmacological effects without daily dosing.
Naltrexone works by attaching to opioid receptors without activating them, preventing opioids from producing their usual euphoric and reinforcing effects. During the active period of the medication, opioid receptor blockade may reduce relapse vulnerability by limiting opioid reward signaling. In alcohol use disorder treatment, changes in reward-related pathways may also influence alcohol reinforcement and craving intensity.
The exact duration of measurable receptor blockade can vary depending on metabolism, body composition, liver function, dosage timing, and other physiological factors. Although the medication is commonly administered monthly, some individuals may experience changes in subjective effects before the next scheduled injection. Clinical monitoring may therefore consider treatment response and overall recovery stability over time.
The medication’s duration does not eliminate the broader neurological, behavioral, emotional, and environmental factors involved in addiction recovery. Cravings, stress exposure, psychiatric symptoms, behavioral conditioning, and relapse vulnerability may still fluctuate during treatment. Medication effects therefore occur within a larger recovery-related framework rather than functioning as a standalone cure.
Vivitrol’s extended duration reflects its role as a long-acting opioid receptor antagonist designed to provide sustained neurological stabilization and relapse protection. Its pharmacological effects differ substantially from medications that activate opioid receptors, such as methadone or buprenorphine. Vivitrol is commonly used in medication-assisted treatment for opioid and alcohol use disorders.